# Study of Lonsurf in Combination With Gemcitabine and Nab-Paclitaxel in Patients With Advanced (PDAC)

> **NCT04046887** · PHASE1 · TERMINATED · sponsor: **Patrick Joseph Loehrer Sr.** · enrollment: 14 (actual)

## Conditions studied

- Pancreatic Cancer
- Pancreatic Ductal Adenocarcinoma

## Interventions

- **DRUG:** Lonsurf
- **DRUG:** Gemcitabine
- **DRUG:** Nab-Paclitaxel

## Key facts

- **NCT ID:** NCT04046887
- **Lead sponsor:** Patrick Joseph Loehrer Sr.
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2019-09-11
- **Primary completion:** 2021-05-10
- **Final completion:** 2023-10-04
- **Target enrollment:** 14 (ACTUAL)
- **Why stopped:** Unable to proceed due to Neulasta difficulties and other complications.
- **Last updated:** 2024-01-05

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04046887

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04046887, "Study of Lonsurf in Combination With Gemcitabine and Nab-Paclitaxel in Patients With Advanced (PDAC)". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04046887. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*